Table 1.
Correlation of clinicopathological features and USP49 expression in pancreatic cancer samples.
| USP49 expression | ||||
|---|---|---|---|---|
| Characteristic | N | Low | High | p-value |
| Gender | 0.4502 | |||
| Male | 58 | 49 | 9 | |
| Female | 32 | 25 | 7 | |
| Age(years) | 0.6729 | |||
| <60 | 49 | 40 | 9 | |
| ≥60 | 40 | 34 | 6 | |
| Tumor size | 0.0844 | |||
| T1 | 2 | 2 | 0 | |
| T2 | 71 | 55 | 16 | |
| T3–T4 | 16 | 16 | 0 | |
| Pathological grades | 0.0371 | |||
| I–II (include II) | 57 | 45 | 12 | |
| II–III (include III) | 32 | 29 | 3 | |
| III–IV (include IV) | 1 | 0 | 1 | |
| Distant metastasis | 1.000 | |||
| Absent | 86 | 72 | 14 | |
| Present | 1 | 1 | 0 | |
| Clinical stages | 0.1779 | |||
| 1 | 37 | 27 | 10 | |
| 2 | 50 | 44 | 6 | |
| 3–4 | 1 | 1 | 0 | |